Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons

被引：12
|
作者：
Keck, James W. [1 ,2 ]
Bulkow, Lisa R. [2 ]
Raczniak, Gregory A. [1 ,2 ]
Negus, Susan E. [3 ]
Zanis, Carolyn L. [2 ]
Bruce, Michael G. [2 ]
Spradling, Philip R. [4 ]
Teshale, Eyasu H. [4 ]
McMahon, Brian J. [2 ,3 ]
机构：
[1] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Arctic Invest Program, Anchorage, AK USA
[3] Alaska Native Tribal Hlth Consortium, Liver Dis & Hepatitis Program, Anchorage, AK USA
[4] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA
来源：
CLINICAL AND VACCINE IMMUNOLOGY | 2014年 / 21卷 / 09期
关键词：
PROTECTION; CHILDREN; IMPACT;
D O I：
10.1128/CVI.00263-14
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Hepatitis B antibody persistence was assessed in individuals who had previously received a vaccine booster. We measured hepatitis B surface antigen antibody (anti-HBs) levels 7 to 9 years post-hepatitis B booster in individuals with primary vaccination at birth. While 95 (91.3%) of 104 participants had detectable anti-HBs (minimum, 0.1 mIU/ml; maximum, 1,029 mIU/ml), only 43 (41%) had protective levels of >= 10 mIU/ml. Pre- and week 4 postbooster anti-HBs levels were significant predictors of hepatitis B immunity at follow-up (P < 0.001). Almost all participants had detectable anti-HBs 7 to 9 years after the hepatitis B vaccine booster, but less than half had levels >= 10 mIU/ml.
引用
收藏
页码：1339 / 1342
页数：4
相关论文
共 50 条
  • [41] Epidemiology of Hepatitis B Virus Infection according to Genotype in Alaska Native People
    Bruce, Michael
    Ching, Lance
    Gounder, Prabhu P.
    Bulkow, Lisa
    Spradling, Philip R.
    Snowball, Mary
    Negus, Susan
    McMahon, Brian J.
    HEPATOLOGY, 2014, 60 : 973A - 973A
  • [42] Investigation of Hepatitis B Surface Antibody Levels in Adults with Routine Hepatitis B Vaccination in Childhood
    Sehmen, Emine
    Yilmaz, Esmeray Mutlu
    Oruc, Muhammet Ali
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2023, 29 (02): : 70 - 74
  • [43] Seroimmunity to Hepatitis B Virus in Children With Inflammatory Bowel Disease: Effects of Booster Vaccination
    Phatak, Uma P.
    Rojas-Velasquez, Danilo
    Pashankar, Dinesh S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2018, 66 (05): : E137 - E137
  • [44] Hepatocellular Carcinoma (HCC) Risk Among Alaska Native (AN) Persons After Resolving Hepatitis B Virus (HBV) Infection: A Nested Case-Control Study
    Gounder, Prabhu P.
    Bulkow, Lisa
    Snowball, Mary
    Negus, Susan
    Spradling, Philip R.
    McMahon, Brian J.
    HEPATOLOGY, 2015, 62 : 272A - 273A
  • [45] Requirement of a Booster Dose of Hepatitis B Vaccine in Children With Thalassemia After 5 Years of Primary Vaccination: A Prospective Study
    Gomber, Sunil
    Yadav, Ravinder
    Dewan, Pooja
    Ramachandran, V. G.
    Puri, A. S.
    INDIAN PEDIATRICS, 2021, 58 (03) : 237 - 240
  • [46] Requirement of a Booster Dose of Hepatitis B Vaccine in Children With Thalassemia After 5 Years of Primary Vaccination: A Prospective Study
    Sunil Gomber
    Ravinder Yadav
    Pooja Dewan
    V. G. Ramachandran
    A. S. Puri
    Indian Pediatrics, 2021, 58 : 237 - 240
  • [47] Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose (vol 76, pg 1180, 2022)
    Bruce, Michael G.
    Bruden, Dana
    Hurlburt, Debby
    Morris, Julie
    Bressler, Sara
    Thompson, Gail
    Lecy, Danielle
    Rudolph, Karen
    Bulkow, Lisa
    Hennessy, Thomas
    Simons, Brenna C.
    Weng, Mark K.
    Nelson, Noele
    McMahon, Brian J.
    HEPATOLOGY, 2024, 80 (05) : E90 - E90
  • [48] Immunogenicity of quadrivalent human papillomavirus vaccine among Alaska Native children aged 9-14 years at 5 years after vaccination
    Davis, Bionca M.
    Blake, Ian
    Panicker, Gitika
    Meites, Elissa
    Thompson, Gail
    Geis, Jesse
    Bruden, Dana
    Fischer, Marc
    Singleton, Rosalyn
    Unger, Elizabeth R.
    Markowitz, Lauri E.
    Bruce, Michael G.
    VACCINE, 2024, 42 (14) : 3277 - 3281
  • [49] Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program
    Hu, Yang-Cheng
    Yeh, Chih-Ching
    Chen, Ruey-Yu
    Su, Chien-Tien
    Wang, Wen-Chang
    Bai, Chyi-Huey
    Chan, Chi-Fen
    Su, Fu Hsiung
    PEERJ, 2018, 6
  • [50] Innate And Adaptive Immune Responses Correlate to Antibody Recall Responses to Hepatitis B Booster Vaccination
    Werner, Jens M.
    Abdalla, Adil
    Gara, Naveen
    Ghany, Marc G.
    Rehermann, Barbara
    HEPATOLOGY, 2013, 58 : 612A - 613A
12345